乐普医疗股价下跌2.76% 子公司创新药完成首例给药

Core Viewpoint - Lepu Medical reported a stock price of 20.05 yuan on August 26, experiencing a decline of 0.57 yuan, or 2.76% from the previous trading day [1] Group 1: Company Overview - Lepu Medical is a healthcare company focused on the research and production of medical devices and pharmaceuticals, with a comprehensive layout in the medical device industry chain [1] - The company's business covers multiple fields, including cardiovascular intervention, in vitro diagnostics, and surgical instruments [1] Group 2: Recent Developments - The company's subsidiary, Minwei Biopharmaceutical, has completed the first dosing of the Phase II clinical trial for its self-developed innovative drug MWN109 injection [1] - Another subsidiary, Sichuan Xingtai Puluo Medical Technology, has received registration approval from the National Medical Products Administration for its injectable cross-linked sodium hyaluronate gel [1] Group 3: Financial Performance - On August 26, the net outflow of main funds was 140.83 million yuan, with a total net outflow of 288.08 million yuan over the past five days [1]